Kestrel Investment Management Corp purchased a new stake in Concentrix Corporation (NASDAQ:CNXC - Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 106,950 shares of the company's stock, valued at approximately $5,950,000. Concentrix accounts for approximately 3.6% of Kestrel Investment Management Corp's holdings, making the stock its 8th largest holding. Kestrel Investment Management Corp owned approximately 0.17% of Concentrix as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors have also made changes to their positions in the stock. Fuller & Thaler Asset Management Inc. lifted its stake in shares of Concentrix by 38.1% in the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 2,981,227 shares of the company's stock valued at $128,998,000 after acquiring an additional 823,228 shares during the last quarter. Copeland Capital Management LLC increased its holdings in Concentrix by 3.0% in the first quarter. Copeland Capital Management LLC now owns 1,373,432 shares of the company's stock valued at $76,418,000 after purchasing an additional 40,226 shares during the period. Lyrical Asset Management LP increased its holdings in Concentrix by 3.4% in the fourth quarter. Lyrical Asset Management LP now owns 1,258,398 shares of the company's stock valued at $54,451,000 after purchasing an additional 41,540 shares during the period. Deprince Race & Zollo Inc. increased its holdings in Concentrix by 55.3% in the fourth quarter. Deprince Race & Zollo Inc. now owns 1,009,133 shares of the company's stock valued at $43,665,000 after purchasing an additional 359,476 shares during the period. Finally, Paradigm Capital Management Inc. NY increased its holdings in Concentrix by 2.7% in the fourth quarter. Paradigm Capital Management Inc. NY now owns 750,142 shares of the company's stock valued at $32,459,000 after purchasing an additional 19,418 shares during the period. 90.34% of the stock is currently owned by institutional investors.
Insiders Place Their Bets
In other news, EVP Cormac J. Twomey sold 500 shares of the stock in a transaction on Wednesday, July 30th. The shares were sold at an average price of $57.91, for a total value of $28,955.00. Following the completion of the sale, the executive vice president directly owned 37,130 shares of the company's stock, valued at $2,150,198.30. This represents a 1.33% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 3.20% of the company's stock.
Wall Street Analysts Forecast Growth
A number of brokerages recently commented on CNXC. Wall Street Zen lowered Concentrix from a "buy" rating to a "hold" rating in a research report on Saturday, June 21st. Bank of America decreased their target price on shares of Concentrix from $65.00 to $61.00 and set a "neutral" rating for the company in a research report on Friday, June 27th. Canaccord Genuity Group restated a "buy" rating and issued a $80.00 target price on shares of Concentrix in a report on Monday, June 30th. Robert W. Baird upped their price target on Concentrix from $62.00 to $72.00 and gave the stock an "outperform" rating in a report on Thursday, June 26th. Finally, Barrington Research reiterated an "outperform" rating and set a $54.00 price target on shares of Concentrix in a report on Tuesday, June 24th. Two equities research analysts have rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $66.75.
View Our Latest Report on CNXC
Concentrix Price Performance
Shares of CNXC stock traded up $0.45 on Tuesday, reaching $46.44. The company's stock had a trading volume of 531,196 shares, compared to its average volume of 810,516. The company has a quick ratio of 1.61, a current ratio of 1.61 and a debt-to-equity ratio of 1.14. Concentrix Corporation has a 12-month low of $36.28 and a 12-month high of $77.00. The company has a market capitalization of $2.93 billion, a P/E ratio of 12.81, a PEG ratio of 0.62 and a beta of 0.53. The stock's 50 day simple moving average is $56.04 and its 200-day simple moving average is $51.81.
Concentrix (NASDAQ:CNXC - Get Free Report) last posted its quarterly earnings results on Thursday, June 26th. The company reported $2.70 earnings per share for the quarter, missing the consensus estimate of $2.76 by ($0.06). The business had revenue of $2.42 billion during the quarter, compared to the consensus estimate of $2.38 billion. Concentrix had a return on equity of 16.31% and a net margin of 2.54%. The business's revenue for the quarter was up 1.5% on a year-over-year basis. During the same period in the prior year, the firm earned $2.69 earnings per share. As a group, equities analysts predict that Concentrix Corporation will post 10.11 earnings per share for the current fiscal year.
Concentrix Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, August 5th. Shareholders of record on Friday, July 25th will be given a $0.3328 dividend. The ex-dividend date is Friday, July 25th. This represents a $1.33 annualized dividend and a yield of 2.9%. Concentrix's dividend payout ratio (DPR) is presently 36.54%.
Concentrix Profile
(
Free Report)
Concentrix Corporation engages in the provision of technology-infused customer experience (CX) solutions worldwide. The company provides CX process optimization, technology innovation, front- and back-office automation, analytics, and business transformation services, across various channels of communication, such as voice, chat, email, social media, asynchronous messaging, and custom applications.
Featured Articles

Before you consider Concentrix, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Concentrix wasn't on the list.
While Concentrix currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.